Abbott GW, Tai KK, Neverisky DL, Hansler A, Hu Z, Roepke TK, Lerner DJ, Chen Q, Liu L, Zupan B, Toth M, Haynes R, Huang X, Demirbas D, Buccafusca R, Gross SS, Kanda VA, Berry GT (2014) KCNQ1, KCNE2, and Na+-coupled solute transporters form reciprocally regulating complexes that affect neuronal excitability. Sci Signal. https://doi.org/10.1126/scisignal.2005025

Article  PubMed  PubMed Central  Google Scholar 

Andreadou I, Bell RM, Botker HE, Zuurbier CJ (2020) SGLT2 inhibitors reduce infarct size in reperfused ischemic heart and improve cardiac function during ischemic episodes in preclinical models. Biochim Biophys Acta Mol Basis Dis 1866:165770. https://doi.org/10.1016/j.bbadis.2020.165770

Article  CAS  PubMed  Google Scholar 

Banerjee SK, McGaffin KR, Pastor-Soler NM, Ahmad F (2009) SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states. Cardiovasc Res 84:111–118. https://doi.org/10.1093/cvr/cvp190

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barquera S, Pedroza-Tobias A, Medina C, Hernandez-Barrera L, Bibbins-Domingo K, Lozano R, Moran AE (2015) Global overview of the epidemiology of atherosclerotic cardiovascular disease. Arch Med Res 46:328–338. https://doi.org/10.1016/j.arcmed.2015.06.006

Article  PubMed  Google Scholar 

Bell RM, Mocanu MM, Yellon DM (2011) Retrograde heart perfusion: the langendorff technique of isolated heart perfusion. J Mol Cell Cardiol 50:940–950. https://doi.org/10.1016/j.yjmcc.2011.02.018

Article  CAS  PubMed  Google Scholar 

Chen J, Williams S, Ho S, Loraine H, Hagan D, Whaley JM, Feder JN (2010) Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members. Diabetes Ther 1:57–92. https://doi.org/10.1007/s13300-010-0006-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen S, Coronel R, Hollmann MW, Weber NC, Zuurbier CJ (2022) Direct cardiac effects of SGLT2 inhibitors. Cardiovasc Diabetol 21:45. https://doi.org/10.1186/s12933-022-01480-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheung NW, Wong VW, McLean M (2006) The hyperglycemia: intensive insulin infusion in infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 29:765–770. https://doi.org/10.2337/diacare.29.04.06.dc05-1894

Article  CAS  PubMed  Google Scholar 

Collet JP, Thiele H, Barbato E, Barthelemy O, Bauersachs J, Bhatt DL, Dendale P, Dorobantu M, Edvardsen T, Folliguet T, Gale CP, Gilard M, Jobs A, Juni P, Lambrinou E, Lewis BS, Mehilli J, Meliga E, Merkely B, Mueller C, Roffi M, Rutten FH, Sibbing D, Siontis GCM, Group ESCSD (2021) 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 42:1289–1367. https://doi.org/10.1093/eurheartj/ehaa575

Article  PubMed  Google Scholar 

Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, Raskin P (2008) Hyperglycemia and acute coronary syndrome: a scientific statement from the american heart association diabetes committee of the council on nutrition, physical activity, and metabolism. Circulation 117:1610–1619. https://doi.org/10.1161/CIRCULATIONAHA.107.188629

Article  PubMed  Google Scholar 

Di Franco A, Cantini G, Tani A, Coppini R, Zecchi-Orlandini S, Raimondi L, Luconi M, Mannucci E (2017) Sodium-dependent glucose transporters (SGLT) in human ischemic heart: a new potential pharmacological target. Int J Cardiol 243:86–90. https://doi.org/10.1016/j.ijcard.2017.05.032

Article  PubMed  Google Scholar 

Dobbins RL, Greenway FL, Chen L, Liu Y, Breed SL, Andrews SM, Wald JA, Walker A, Smith CD (2015) Selective sodium-dependent glucose transporter 1 inhibitors block glucose absorption and impair glucose-dependent insulinotropic peptide release. Am J Physiol Gastrointest Liver Physiol 308:G946-954. https://doi.org/10.1152/ajpgi.00286.2014

Article  CAS  PubMed  Google Scholar 

Esdaile H, Hill N, Mayet J, Oliver N (2023) Glycaemic control in people with diabetes following acute myocardial infarction. Diabetes Res Clin Pract 199:110644. https://doi.org/10.1016/j.diabres.2023.110644

Article  PubMed  Google Scholar 

Fazel R, Fang J, Kline-Rogers E, Smith DE, Eagle KA, Mukherjee D (2005) Prognostic value of elevated biomarkers in diabetic and non-diabetic patients admitted for acute coronary syndromes. Heart 91:388–390. https://doi.org/10.1136/hrt.2003.032797

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferte L, Marino A, Battault S, Bultot L, Van Steenbergen A, Bol A, Cumps J, Ginion A, Koepsell H, Dumoutier L, Hue L, Horman S, Bertrand L, Beauloye C (2021) New insight in understanding the contribution of SGLT1 in cardiac glucose uptake: evidence for a truncated form in mice and humans. Am J Physiol Heart Circ Physiol 320:H838–H853. https://doi.org/10.1152/ajpheart.00736.2019

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han S, Hagan DL, Taylor JR, Xin L, Meng W, Biller SA, Wetterau JR, Washburn WN, Whaley JM (2008) Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats. Diabetes 57:1723–1729. https://doi.org/10.2337/db07-1472

Article  CAS  PubMed  Google Scholar 

Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, Butler A, Lee MJ, Wilk AJ, Darby C, Zager M, Hoffman P, Stoeckius M, Papalexi E, Mimitou EP, Jain J, Srivastava A, Stuart T, Fleming LM, Yeung B, Rogers AJ, McElrath JM, Blish CA, Gottardo R, Smibert P, Satija R (2021) Integrated analysis of multimodal single-cell data. Cell 184(3573–3587):e3529. https://doi.org/10.1016/j.cell.2021.04.048

Article  CAS  Google Scholar 

Heusch G (2020) Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol 17:773–789. https://doi.org/10.1038/s41569-020-0403-y

Article  PubMed  Google Scholar 

Inoue T, Takemura M, Fushimi N, Fujimori Y, Onozato T, Kurooka T, Asari T, Takeda H, Kobayashi M, Nishibe H, Isaji M (2017) Mizagliflozin, a novel selective SGLT1 inhibitor, exhibits potential in the amelioration of chronic constipation. Eur J Pharmacol 806:25–31. https://doi.org/10.1016/j.ejphar.2017.04.010

Article  CAS  PubMed  Google Scholar 

Ishida N, Saito M, Sato S, Tezuka Y, Sanbe A, Taira E, Hirose M (2021) Mizagliflozin, a selective SGLT1 inhibitor, improves vascular cognitive impairment in a mouse model of small vessel disease. Pharmacol Res Perspect 9:e00869. https://doi.org/10.1002/prp2.869

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jansson D, Ng AC, Fu A, Depatie C, Al Azzabi M, Screaton RA (2008) Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2. Proc Natl Acad Sci USA 105:10161–10166. https://doi.org/10.1073/pnas.0800796105

Article  PubMed  PubMed Central  Google Scholar 

Jespersen NR, Lassen TR, Hjortbak MV, Støttrup NB, Bøtker HE (2017) Sodium glucose transporter 2 (SGLT2) inhibition does not protect the myocardium from acute ischemic reperfusion injury but modulates post ischemic mitochondrial function. Cardiovasc Pharm Open Access 6:1–3. https://doi.org/10.4172/2329-6607.1000210

Article  CAS  Google Scholar 

Koenig AL, Shchukina I, Amrute J, Andhey PS, Zaitsev K, Lai L, Bajpai G, Bredemeyer A, Smith G, Jones C, Terrebonne E, Rentschler SL, Artyomov MN, Lavine KJ (2022) Single-cell transcriptomics reveals cell-type-specific diversification in human heart failure. Nat Cardiovasc Res 1:263–280. https://doi.org/10.1038/s44161-022-00028-6

Article  PubMed  PubMed Central  Google Scholar 

Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, Baglaenko Y, Brenner M, Loh PR, Raychaudhuri S (2019) Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods 16:1289–1296. https://doi.org/10.1038/s41592-019-0619-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lim VG, Bell RM, Arjun S, Kolatsi-Joannou M, Long DA, Yellon DM (2019) SGLT2 inhibitor, canagliflozin, attenuates myocardial infarction in the diabetic and nondiabetic heart. JACC Basic Transl Sci 4:15–26. https://doi.org/10.1016/j.jacbts.2018.10.002

Article  PubMed  PubMed Central  Google Scholar 

Long DA, Woolf AS, Suda T, Yuan HT (2001) Increased renal angiopoietin-1 expression in folic acid-induced nephrotoxicity in mice. J Am Soc Nephrol 12:2721–2731. https://doi.org/10.1681/ASN.V12122721